China's Payments Giant AliPay Takes Measures Against OTC Crypto Trading via Its Platform
Chinese mobile payment app Alipay is toughening its stance towards users who use their Alipay accounts for over-the-counter Bitcoin trading.
According to Beijing News, Alipay is now taking measures to restrict and even permanently block those accounts that use its network to transact Bitcoin OTC, as well as establishing an inspection system for “key websites and accounts.”
This January, a fresh crackdown from Beijing notably saw fringe trading platforms such as peer-to-peer (P2P) and OTC resources banned, adding to a blanket embargo on crypto-to-fiat trading and initial coin offerings (ICOs) in place since September 2017.
Beijing News further cites sources from Ant Financial that claim the financial services giant will also conduct a “risk prevention” program intended to educate users about the dangers of false crypto-related “propaganda.”
Jing’s harsh stance was nonetheless counterbalanced by his strong optimism about blockchain. In 2017, the CEO said that he “definitely” expected to see the technology becoming “deeply” implemented into Alipay in future, eventually acting as a base protocol for the payment app.
This June, Ant Financial entered into “definitive agreements” with investors to secure $14 bln in a Series C equity financing round, intending to spend the capital on pursuing blockchain and related technological innovations.
Today’s news from Alipay follows close upon the heels of an onslaught of toughened anti-crypto measures in China, including this week’s ban on all commercial venues from hosting any crypto-related events in Beijing’s Chaoyang district.
As reported August 21, China’s leading social media platform WeChat has permanently blocked a number of crypto and blockchain related accounts suspected of publishing crypto “hype” in violation of regulations introduced earlier this month.
New measures are also reportedly underway to toughen the “clean-up” of third-party crypto payment channels, including those used by OTC platforms.